Adalimumab for the Management of Post-operative Crohn's Disease (CD)
Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
Cimzia Versus Mesalamine for Crohn's Recurrence
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
† Study has passed its completion date and status has not been verified in more than two years.